Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
22,949,296
-
Share change
-
+25,142
-
Total reported value
-
$1,668,870,325
-
Put/Call ratio
-
204%
-
Price per share
-
$72.72
-
Number of holders
-
250
-
Value change
-
-$13,474,819
-
Number of buys
-
108
-
Number of sells
-
144
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q1 2020
As of 31 Mar 2020,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
250 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,949,296 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, CARDINAL CAPITAL MANAGEMENT LLC /CT, MACQUARIE GROUP LTD, WASATCH ADVISORS INC, Conestoga Capital Advisors, LLC, and VILLERE ST DENIS J & CO LLC.
This page lists
250
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.